معرفی
Gary Lopaschuk serves as an Adjunct Professor in the Department of Pharmacology at the University of Alberta, where he maintains an active research program focused on cardiac energy metabolism. His work bridges pharmacological interventions with metabolic regulation in heart disease, diabetes, and neonatal cardiac development.
His educational background includes:
- PhD in Pharmacology and Toxicology from the University of British Columbia (1983)
- Post-Doctoral Fellowship at The Milton S. Hershey Medical Centre Department of Physiology (1983-1985)
Dr. Lopaschuk's research centers on the molecular regulation of cardiac fuel utilization, particularly the pathological dominance of fatty acids in diabetic hearts and post-infarction conditions. His laboratory has defined critical mechanisms behind the fetal-to-neonatal metabolic switch and developed pharmacological strategies to optimize cardiac energy metabolism. Current investigations focus on enzyme regulation in diabetic hearts and mitochondrial protection following ischemic injury.
Analysis of his 2016-2017 publications reveals a cohesive research trajectory emphasizing metabolic modulators for heart disease, with recurring themes in fatty acid oxidation regulation, mitochondrial efficiency, and post-translational modifications. His work spans basic molecular mechanisms to clinical applications, particularly in diabetes-related cardiac complications and ischemic injury protection.
Professional recognition includes:
- AHFMR Scientist fellowship
Dr. Lopaschuk's laboratory at the Heritage Medical Research Centre (4-23 Heritage Medical Research Centre) generates sustained research output through collaborations with national and international teams. His work has contributed to major scientific statements including the American Heart Association's guidelines on cardiac metabolism assessment. Current projects focus on translating metabolic insights into therapeutic approaches for diabetic cardiomyopathy and neonatal cardiac surgery protection.
His research program operates within the University of Alberta's cardiovascular research ecosystem, utilizing molecular, biochemical, and physiological methodologies to address cardiac metabolism questions with direct clinical relevance.
